Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Large Kaiser Permanente study finds a 13% greater risk of being diagnosed with dementia after a diagnosis of atrial fibrillation, with stronger associations seen in younger, healthier people.
People attending schools in states with higher state-level educational quality are less likely to develop dementia in late life, according to a new Kaiser Permanente analysis published in JAMA Neurology.
Kaiser Permanente study finds postmenopausal women with cancer report a greater decline in physical function than women who have not had cancer.
Kaiser Permanente study highlights the need for more research on the best patient-centered care for people managing both conditions.
A study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The rate of dementia decreased over time for both groups but remained higher for those with HIV, reported research published in the journal AIDS.
New Kaiser Permanente study aims to help providers improve the health of patients most likely to sustain high medical costs, frequently use the emergency department, or need to be hospitalized.
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.